MedPath

The mucosal injury of small intestine in regular users of COX-2 selective inhibitor (Celecoxib) investigated by capsule endoscopy

Not Applicable
Conditions
Mucosal injury of small intestine due to COX-2 selective inhibitor
Registration Number
JPRN-UMIN000007403
Lead Sponsor
Department of Gastroenterology, The University of Tokyo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients taking misoprostol 2) Patients taking other NSAIDs, steroid, anti-platelet agents except aspirin, anti-coagulants, or anti-cancer drugs 3) Patients with contraindication to capsule endoscopy 4) Patients with active bleeding lesions 5) Severely ill patients

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath